The Serum Concentrations of Hedgehog-Interacting Protein, a Novel Biomarker, Were Decreased in Overweight or Obese Subjects

• Published in: Journal of clinical medicine Vol. 10; no. 4; p. 742
• Main Authors: Chou, Hsuan-Wen, Hung, Hao-Chang, Lin, Ching-Han, Lin, An-Chi, Du, Ye-Fong, Cheng, Kai-Pi, Li, Chung-Hao, Chang, Chih-Jen, Wu, Hung-Tsung, Ou, Horng-Yih
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 12.02.2021; MDPI
• Subjects: Adipocytes; Blood pressure; Body mass index; Cholesterol; Clinical medicine; Diabetes; Glucose; High density lipoprotein; Homeostasis; Insulin resistance; Laboratories; Lipoproteins; Obesity; Overweight; Proteins; Regression analysis; Triglycerides; Variance analysis; United States > US; Japan; Taiwan; hedgehog-interacting protein; impaired glucose tolerance; normal glucose tolerance; impaired fasting glucose; newly diagnosed diabetes
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm10040742

Although it was known that obesity is an independent risk factor for metabolic disorders including diabetes, the factors that link these diseases were obscure. The Hedgehog-interacting protein (Hhip) is a negative regulator in tissue remodeling, and inhibits the proliferation of adipocytes, and promotes their differentiation. In addition, Hhip was positively associated with diabetes. However, the relationship between Hhip and obesity in the human body remains unclear. An analysis of the relationship between Hhip and normal weight, overweight, and obesity levels. Participants receiving a physical checkup were recruited. Anthropometric and biochemical data were collected. Serum Hhip levels were determined by enzyme-linked immunosorbent assay (ELISA). Subjects were classified into normal-weight, overweight, and obese groups based on their body mass index (BMI). The association between Hhip and obesity was examined by multivariate linear regression analysis. In total, 294 subjects who were either of a normal weight (n = 166), overweight (n = 90), or obese (n = 38) were enrolled. Hhip concentrations were 6.51 ± 4.86 ng/mL, 5.79 ± 4.33 ng/mL, and 3.97 ± 3.4 ng/mL in normal-weight, overweight, and obese groups, respectively (p for trend = 0.032). Moreover, the regression analysis showed that BMI (β = −0.144, 95% confidence interval (CI) = −0.397−0.046, p = 0.013) was negatively associated with Hhip concentrations after adjusting for sex and age. Being overweight (β = −0.181, 95% CI = −3.311−0.400, p = 0.013) and obese (β = −0.311, 95% CI = −6.393−2.384, p < 0.001) were independently associated with Hhip concentrations after adjusting for sex, age, fasting plasma glucose, the insulin level, and other cardiometabolic risk factors. Our results showed that overweight and obese subjects had lower Hhip concentrations than those of normal weight. Being overweight and obese were negatively associated with Hhip concentrations. Hhip might be a link between obesity and diabetes.